Pay in 4 interest-free payments of $5.38 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
The two peptides work together to manage post-meal metabolism through different mechanisms: Insulin drives glucose into cells, lowering blood glucose levels
Liraglutide attenuates type 2 diabetes mellitus-associated non-alcoholic fatty liver disease by activating AMPK/ACC signaling and inhibiting ferroptosis
Research applications of the KLOW combination include investigation of multi-modal tissue repair mechanisms, studies of peptide synergism and interaction effects, examination of copper-peptide delivery systems, and exploration of combined anti-inflammatory and regenerative approaches
Additionally, you can consider combining it with other anti-ageing skincare services
As of the time of writing, both agents remain in clinical development and have not received a marketing authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA)
